Global Leukapheresis Market is Expected to Reach USD 41.07 Million by 2025 : Fior Markets

NEXT STORY
Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial Role of Nomacopan as an Inhibitor of both C5 and LTB4 in the Ongoing Phase I/II AKC Trial
PREV STORY
Salarius Pharmaceuticals to Present at Two Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apricus Biosciences Announces $3.7 Million Private Placement Priced At-The-Market

SAN DIEGO, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Merus Announces Second Quarter 2017 Financial Results and Highlights Recent Progress

UTRECHT, The Netherlands, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology ...

author_avatar
NASDAQ Market News

:DentalPlans – How To Spring Clean Your Dental Routine

PLANTATION, Fla., April 12, 2016 (GLOBE NEWSWIRE) -- Could your dental care routine use ...

author_avatar
NASDAQ Market News